2Eichinger S,Ever JL,Glasier A,et al.Venous thromboembolism in wom- en:a specific reproductive health risk[J].Hum Reprod Update,2013,19(5): 471-482.
3Faber MT,Jensen A,Frederiksen K,et al.Oral coniraceptive use and im- pact of cumulative intake of estrogen and progestin on risk of ovarian cancer[J].cancer causes control,2013,24(12):2197-2206.
5Rahman M,Berenson AB.Predictors of higher bone mineral density loss and nse of depot medroxyprogesterone acetate[J].Obstet Gynecol,2010,115 (1):35-40.
6Parkin L,Sharples K,Hernandez PK,et al.Risk of venous thromboembolism in users of oral contraceptives containing dmspirenone or levonorgestrel: nested case-conlrol study based on UK General Practice Research Database [J].BMJ,2011,342(4): 1-7.
7Ziller M,Ziller V,Haas G,et al.Risk of venous thrombosis in users of hormonal contraceptives in Gemmn gynaecological practices:a patient database analysis[J].Arch Gynecol Obstet,2014,289(2):413-419.
9Schlesselman JJ.Risk of endometrial cancer in relation to use of com- bined oral contraceptives:a practitioner's guide to meta-analysis[J].Hum Reprod, 1997,12(9): 1851-1863.
10Beral V,Hannaford P,Kay C.Oral contraceptive use and malignancies of the genital tract.Results of the Royal College of General Practitioner's oral contraception study[J].Lancet,1988,2(8624):1331-1335.
8Guleria K,Agarwel N,Mishra K,et al.Evaluation of endometrial steroid receptors and cell mitotic activity in women using copper intrauterine device:Can Cu-T prevent endometrial cancer[J].J Obstet Gynaecol Res,2004,30(3):181-187.
9姚中本.官腔镜临床应用942例分析.中华妇产科杂志,1986,21:48-48.
10Resenblazt K,Thomas DB.Intrauterine devices and endometrial cancer.The WHO collaborative study of neoplasia and steroid Contraceptives[J].Contraception,1996.54(6):329-332.
